KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Abbott Laboratories (ABT) over the last 15 years, with Q3 2025 value amounting to $17.3 billion.

  • Abbott Laboratories' Long-Term Deferred Tax rose 11617.78% to $17.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 billion, marking a year-over-year increase of 11617.78%. This contributed to the annual value of $16.5 billion for FY2024, which is 13191.49% up from last year.
  • Latest data reveals that Abbott Laboratories reported Long-Term Deferred Tax of $17.3 billion as of Q3 2025, which was up 11617.78% from $17.3 billion recorded in Q2 2025.
  • Abbott Laboratories' Long-Term Deferred Tax's 5-year high stood at $17.3 billion during Q3 2025, with a 5-year trough of $3.7 billion in Q1 2021.
  • Its 5-year average for Long-Term Deferred Tax is $8.2 billion, with a median of $6.5 billion in 2023.
  • As far as peak fluctuations go, Abbott Laboratories' Long-Term Deferred Tax skyrocketed by 795.3% in 2021, and later surged by 13191.49% in 2024.
  • Over the past 5 years, Abbott Laboratories' Long-Term Deferred Tax (Quarter) stood at $5.2 billion in 2021, then grew by 15.75% to $6.0 billion in 2022, then rose by 17.64% to $7.1 billion in 2023, then skyrocketed by 131.91% to $16.5 billion in 2024, then increased by 5.22% to $17.3 billion in 2025.
  • Its Long-Term Deferred Tax was $17.3 billion in Q3 2025, compared to $17.3 billion in Q2 2025 and $16.8 billion in Q1 2025.